eromycin
eli lilly and company (nz) limited - erythromycin estolate 720mg equivalent to 500 mg erythromycin base; ; - tablet - 500 mg - active: erythromycin estolate 720mg equivalent to 500 mg erythromycin base excipient: erythrosine glycerol hyprolose hypromellose magnesium stearate methanol methylated spirits methylene chloride purified water quinoline yellow starch sunset yellow fcf titanium dioxide trichloroethane white beeswax
seromycin- cycloserine capsule
parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - cycloserine 250 mg in 250 mg - seromycin is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram–positive and gram–negative bacteria, especially enterobacter spp. and escherichia coli . it is generally no more and is usually less effective than other antimicrobial agents in the treatment of urinary tract infections caused by bacteria other than mycobacteria. use of seromycin in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptib
eromycin tablets (pom)
erythromycin 250mg
seromycin- cycloserine capsule
parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - indications and usage seromycin ® is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin ® should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin ® may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram- positive and gram-negative bacteria. use of seromycin ® in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptible to the drug. contraindications administration is contraindicated in patients with any of the following: • hypersensitivity to seromycin
eromycin
eli lilly and company (nz) limited - erythromycin estolate 360mg equivalent to 250 mg erythromycin base; - tablet - 250 mg - active: erythromycin estolate 360mg equivalent to 250 mg erythromycin base
aeromycin vial inj
astrum hc. - polymyxin b sulph. - inj - 500,000u. - vial
eromycin
eli lilly and company (nz) limited - erythromycin estolate 360mg equivalent to 250 mg erythromycin base; - capsule - 250 mg - active: erythromycin estolate 360mg equivalent to 250 mg erythromycin base excipient: erythrosine gelatin hydrated silica iron oxide red iron oxide yellow liquid paraffin magnesium stearate opacode purified talc quinoline yellow tekprint black sw-9008 titanium dioxide water
eromycin
eli lilly and company (nz) limited - erythromycin estolate 36 mg/ml equivalent to 25 mg/ml erythromycin base; - oral suspension - 125 mg/5ml - active: erythromycin estolate 36 mg/ml equivalent to 25 mg/ml erythromycin base excipient: citric acid monohydrate dimeticone dispersible cellulose imitation orange juice methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium calcium edetate sodium chloride sodium citrate dihydrate sodium laurilsulfate sucrose sunset yellow fcf
eromycin
eli lilly and company (nz) limited - erythromycin estolate 72 mg/ml equivalent to 50 mg/ml erythromycin base; - oral suspension - 250 mg/5ml - active: erythromycin estolate 72 mg/ml equivalent to 50 mg/ml erythromycin base excipient: citric acid monohydrate dimeticone dispersible cellulose imitation 0range juice methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium calcium edetate sodium chloride sodium citrate dihydrate sodium laurilsulfate sucrose sunset yellow fcf